Showing results (1331-1340 of 1,566) with videos related to

Sort By:
Pageof 157
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2013
EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesionsJuliana Schussel, Xian Chong Zhou, Zhe Zhang, et al.
Cancer Research|March 22, 2019
4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck CancerZhiyong Wang, Xiaodong Feng, Alfredo A Molinolo, et al.
Plos One|March 27, 2014
Novel insight into mutational landscape of head and neck squamous cell carcinomaDaria A Gaykalova, Elizabeth Mambo, Ashish Choudhary, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Perioperative Red Cell Line Trend following Robot-Assisted Radical Prostatectomy for Prostate CancerFrancesco Di Bello, Ernesto Di Mauro, Claudia Collà Ruvolo, et al.
British Journal of Haematology|August 3, 2021
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analysesDaniel J Landsburg, Stefan K Barta, Radhakrishnan Ramchandren, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 28, 2010
Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancyKavita Malhotra Pattani, Zhe Zhang, Semra Demokan, et al.
Journal of Personalized Medicine|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic CancerGiovanni Salzano, Francesco Perri, Fabio Maglitto, et al.
Cancer Biology & Therapy|September 23, 2015
Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytesVishalakshi Nanjappa, Santosh Renuse, Gajanan J Sathe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2020
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populationsEnriqueta Felip, Andrea Ardizzoni, Tudor Ciuleanu, et al.
Pageof 157